Breaking News Instant updates and real-time market news.

PSDV

pSivida

$2.94

-0.07 (-2.33%)

07:09
10/04/16
10/04
07:09
10/04/16
07:09

pSivida Phase 3 trial of Medidur meets enrollment target

pSivida announced that its second Phase 3 trial of Medidur in chronic, non-infectious posterior segment uveitis met its target enrollment of 150 patients. The trial is being conducted in clinical sites in India, with the same study design and endpoints as the first Phase 3 trial conducted in the U.S., EU and India. The results of both Phase 3 trials will support U.S. product registration, with NDA submission planned for the second half of 2017. Filing for EU registration remains on track for Q1 of 2017. This first Medidur trial met the primary efficacy endpoint of prevention of recurrence of posterior segment uveitis at six months in December 2015. Primary efficacy endpoint readout in the second study is expected in the second half of 2017.

PSDV pSivida
$2.94

-0.07 (-2.33%)

12/17/15
NORL
12/17/15
NO CHANGE
Target $10
NORL
Outperform
Alimera sale would have implications for pSivida, says Northland
Northland analyst Suraj Kalia noted the Reuters report that Alimera Sciences (ALIM), a licensee of pSivida (PSDV), is exploring strategic alternatives. If Alimera get bought, the acquirer could keep its current contractual arrangement with pSivida, under which it is entitled to 20% of "net profits" on sales of Iluvien in DME, in place, or could try to negotiate an upfront lump sum payment to pSivida for Iluvien, the analyst stated. Kalia keeps an Outperform rating and $10 price target on pSivida shares.
12/22/15
NORL
12/22/15
NO CHANGE
Target $10
NORL
Outperform
pSivida' Meddidur results a big positive, says Northland
Northland analyst Suraj Kalia said pSivida announced strong Phase III results from its Medidur uveitis study. Overall, the data improves pSivida's bargaining position if a strategic buyer steps in for partner Alimera, and it positions pSivida strongly from a go-direct strategy perspective, the analyst reported. Kalia rates pSivida an Outperform with a $10 price target on shares.
12/23/15
LTCO
12/23/15
NO CHANGE
Target $12.5
LTCO
Buy
pSivida price target raised to $12.50 from $8 at Ladenburg
Ladenburg analyst Matthew Kaplan raised pSivida's price target to $12.50 from $8 and reiterated his Buy rating following the "outstanding" top-line data for first Medidur Phase 3 trial in treating chronic noninfectious posterior uveitis. Kaplan said the data presents a strong case that the FDA may allow Medidur NDA filing without completion of the 2nd Phase 3 study.
06/23/16
06/23/16
NO CHANGE

Outperform
pSivida could see positive catalysts shortly, says FBR Capital
FBR Capital analyst Vernon Bernardino thinks pSivida is on track to announce the 12-month data from the first Medidur Phase III trial, which he expects to be a significant catalyst, in July and that an IND filing for a Durasert osteoarthritis product by the company's partner is on track to be announced in the next few weeks. Given the company's upcoming catalysts, its potential to turn positive on cash flow in the near-term and its attractive potential as an acquisition target, the firm reiterates its Outperform rating on pSivida.

TODAY'S FREE FLY STORIES

QTM

Quantum

$6.07

-0.07 (-1.14%)

, GUID

Guidance Software

16:20
01/16/18
01/16
16:20
01/16/18
16:20
Hot Stocks
Quantum appoints Patrick Dennis as CEO »

Quantum (QTM) announced…

QTM

Quantum

$6.07

-0.07 (-1.14%)

GUID

Guidance Software

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

16:20
01/16/18
01/16
16:20
01/16/18
16:20
Options
Closing CBOE SPX and VIX Index summary for January 16th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$335.16

-1.05 (-0.31%)

, ADNT

Adient

$82.18

-0.51 (-0.62%)

16:19
01/16/18
01/16
16:19
01/16/18
16:19
Hot Stocks
Boeing, Adient launch new company to design, build airplane seats »

Boeing (BA) and Adient…

BA

Boeing

$335.16

-1.05 (-0.31%)

ADNT

Adient

$82.18

-0.51 (-0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 29

    Jan

  • 31

    Jan

  • 21

    Feb

CLD

Cloud Peak

$5.31

-0.24 (-4.32%)

16:18
01/16/18
01/16
16:18
01/16/18
16:18
Hot Stocks
Cloud Peak Energy signs long-term coal export pact with JERA Trading »

Cloud Peak Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

GDEN

Golden Entertainment

$31.70

-0.48 (-1.49%)

16:18
01/16/18
01/16
16:18
01/16/18
16:18
Syndicate
Golden Entertainment files to sell 6.5M shares of common stock for holders »

J.P. Morgan and Morgan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATEN

A10 Networks

$7.31

-0.27 (-3.56%)

16:18
01/16/18
01/16
16:18
01/16/18
16:18
Hot Stocks
Breaking Hot Stocks news story on A10 Networks »

A10 Networks down 2%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATEN

A10 Networks

$7.31

-0.27 (-3.56%)

16:17
01/16/18
01/16
16:17
01/16/18
16:17
Earnings
A10 Networks reports preliminary Q4 adjusted EPS 5c-6c, consensus 3c »

Reports preliminary Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMT

Core Molding

$20.85

-0.49 (-2.30%)

16:17
01/16/18
01/16
16:17
01/16/18
16:17
Hot Stocks
Core Molding acquires Horizon Plastics for approximately $63M in cash »

Core Molding announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIVE

Aerohive

$5.70

-0.19 (-3.23%)

16:17
01/16/18
01/16
16:17
01/16/18
16:17
Earnings
Aerohive cuts Q4 revenue view to roughly $37M from $40M-$42M, consensus $40.89M »

The Company expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

16:17
01/16/18
01/16
16:17
01/16/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$62.07

3.41 (5.81%)

, UNH

UnitedHealth

$233.29

4.65 (2.03%)

16:16
01/16/18
01/16
16:16
01/16/18
16:16
General news
On The Fly: Top stock stories for Tuesday »

Stocks opened sharply…

MRK

Merck

$62.07

3.41 (5.81%)

UNH

UnitedHealth

$233.29

4.65 (2.03%)

GE

General Electric

$18.21

-0.55 (-2.93%)

NSRGY

Nestle

$86.20

1.1 (1.29%)

QCOM

Qualcomm

$68.25

2.87 (4.39%)

AVGO

Broadcom

$263.25

-1.04 (-0.39%)

GM

General Motors

$44.19

0.12 (0.27%)

HAWK

Blackhawk

$45.08

8.575 (23.49%)

SCOR

comScore

$24.45

-4.65 (-15.98%)

UAA

Under Armour; also tag UA

$13.82

-1.305 (-8.63%)

UA

Under Armour; also tag UAA

$12.48

-1.665 (-11.78%)

NXPI

NXP Semiconductors

$119.40

-0.18 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 16

    Jan

  • 16

    Jan

  • 18

    Jan

  • 24

    Jan

  • 25

    Jan

  • 31

    Jan

  • 02

    Feb

  • 06

    Feb

  • 08

    Feb

  • 06

    Mar

  • 08

    Mar

  • 25

    Mar

  • 03

    Apr

  • 23

    Apr

  • 23

    Oct

XON

Intrexon

$13.78

-0.935 (-6.36%)

16:16
01/16/18
01/16
16:16
01/16/18
16:16
Syndicate
Intrexon files to sell common stock, no amount given »

JMP Securities LLC is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

16:16
01/16/18
01/16
16:16
01/16/18
16:16
Technical Analysis
NYSE market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MET

MetLife

$51.85

-1.48 (-2.78%)

16:16
01/16/18
01/16
16:16
01/16/18
16:16
Hot Stocks
MetLife to merger General American Life with and into Metropolitan Tower »

MetLife announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 12

    Jun

OSTK

Overstock.com

$70.25

-8.7 (-11.02%)

, KODK

Kodak

$8.43

-0.775 (-8.42%)

16:13
01/16/18
01/16
16:13
01/16/18
16:13
Hot Stocks
Overstock's tZERO to trade KODAKCoin on future security token trading platform »

Overstock.com's…

OSTK

Overstock.com

$70.25

-8.7 (-11.02%)

KODK

Kodak

$8.43

-0.775 (-8.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EHTH

eHealth

$17.52

-0.045 (-0.26%)

16:13
01/16/18
01/16
16:13
01/16/18
16:13
Hot Stocks
eHealth CFO David Francis to transition to role of Chief Operating Officer »

eHealth announced changes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EHTH

eHealth

$17.52

-0.045 (-0.26%)

16:12
01/16/18
01/16
16:12
01/16/18
16:12
Earnings
eHealth sees FY17 adjusted EBITDA ($15.5M)-($14.5M) »

Sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EHTH

eHealth

$17.52

-0.045 (-0.26%)

16:12
01/16/18
01/16
16:12
01/16/18
16:12
Hot Stocks
eHealth acquires GoMedigap for $20M »

eHealth announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCBS

Nicolet Bankshares

$54.06

-1.82 (-3.26%)

16:11
01/16/18
01/16
16:11
01/16/18
16:11
Earnings
Nicolet Bankshares reports Q4 EPS 88c, consensus 81c »

Reports return on average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EHTH

eHealth

$17.52

-0.045 (-0.26%)

16:11
01/16/18
01/16
16:11
01/16/18
16:11
Earnings
eHealth sees Q4 adjusted EBITDA ($19.3M)-($18.3M) »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPB

Mid Penn Bancorp

$37.00

-0.5 (-1.33%)

16:10
01/16/18
01/16
16:10
01/16/18
16:10
Hot Stocks
Mid Penn Bancorp, First Priority Financial Corp agree to merge »

Mid Penn Bancorp and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBVX

MabVax Therapeutics

$0.95

0.0512 (5.71%)

16:10
01/16/18
01/16
16:10
01/16/18
16:10
Syndicate
Breaking Syndicate news story on MabVax Therapeutics »

MabVax Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TAHO

Tahoe Resources

$4.65

-0.285 (-5.78%)

16:10
01/16/18
01/16
16:10
01/16/18
16:10
Hot Stocks
Tahoe Resources announces record gold production of 445,000 ounces in 2017 »

Tahoe Resources reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

GCO

Genesco

$33.95

-1.35 (-3.82%)

16:09
01/16/18
01/16
16:09
01/16/18
16:09
Hot Stocks
Legion Partners reports 5.19% stake in Genesco »

Legion Partners, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRZ

New Residential

$17.65

-0.0938 (-0.53%)

16:09
01/16/18
01/16
16:09
01/16/18
16:09
Syndicate
New Residential files to sell $25M shares of common stock »

Credit Suisse Securities,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.